Last reviewed · How we verify

NCT04046510

Comparaison of 3 Protocols of Ocytocin Administration in C Section

Completed NA Last updated 6 August 2019
What this trial tests

NA trial testing Ocytocin in Cesarean Section Complications in 180 participants. Completed in 31 July 2019.

Timeline
1 September 2018
Primary endpoint
31 March 2019
31 July 2019

Quick facts

Lead sponsorMongi Slim Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment180
Start date1 September 2018
Primary completion31 March 2019
Estimated completion31 July 2019
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

Mongi Slim Hospital

Who can join

18 and older, female only, with Cesarean Section Complications or Oxytocin Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare 3 doses of ocytocin in bolus injection and contnious perfusion during C section. these doses determined by: high, intermediate and low doses, were administred to parturients during elective or urgent C section under spinal anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

Other Mongi Slim Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04046510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing